Sean A. Power serves as the Chief Financial Officer, Treasurer, and Corporate Secretary at TG Therapeutics Inc., a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. In his role, Power is responsible for overseeing the financial operations, strategic planning, and corporate governance of the company. His leadership has been instrumental in guiding TG Therapeutics through various stages of growth and development, ensuring the company's financial health and compliance with regulatory standards. Before joining TG Therapeutics, Power amassed extensive experience in the financial sector, particularly within the life sciences industry. He previously held senior financial positions at several prominent companies, where he honed his skills in financial management, capital raising, and investor relations. Power's strategic financial acumen has been a key factor in TG Therapeutics' successful fundraising efforts and partnerships, which have enabled the company to advance its clinical programs and expand its pipeline of innovative therapies. His dedication to the company's mission and his ability to navigate complex financial landscapes have solidified his reputation as a valuable asset to TG Therapeutics. Under Power's stewardship, TG Therapeutics has achieved significant milestones, including the successful launch of its first commercial product and the progression of its clinical trials. His proactive approach to financial strategy and risk management has positioned the company for sustained growth and success in the competitive biopharmaceutical market. Power's contributions extend beyond his financial expertise; he plays a crucial role in shaping the company's corporate culture and fostering a collaborative environment that drives innovation and excellence.